Latest filing published 14 Oct 2026 for Verizon Communications INC, €42k. Read the official filing
This profile gathers the share dealings of Kyle Malady across 2 companies, led by Verizon Communications Inc and Dexcom Inc. Between 21 May 2021 and 13 October 2026, the trades on record add up to 40 filings.
No open-market purchase appears, only 23 sales worth €6.5M. Besides market trades, the filings include 9 share grants and 8 option exercises. 2026 to date brings no purchases and 8 sales.
The latest filing, published on 14 October 2026, reports an open-market sale of €42k in Verizon Communications Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations